"Silymarin", a promising pharmacological agent for treatment of diseases
about
Protective effect of silymarin against chemical-induced cardiotoxicityProfile of bioactive compounds in Nymphaea alba L. leaves growing in Egypt: hepatoprotective, antioxidant and anti-inflammatory activityProtective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver.Effects of silymarin on neuropathic pain and formalin-induced nociception in mice.Protective Effects of Silymarin, Alone or in Combination with Chlorogenic Acid and/or Melatonin, Against Carbon Tetrachloride-induced Hepatotoxicity.Teratogenic effects of silymarin on mouse fetuses.Hepatoprotective effect of silymarin.Liver function and anemia pathogenesis in Iranian traditional medicine.Effects of gamma rays on rat testis tissue according to the morphological parameters and immunohistochemistry: radioprotective role of silymarin.Effects of Resveratrol and Other Polyphenols on Sirt1: Relevance to Brain Function During Aging.Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity.Role of garlic extract and silymarin compared to dimercaptosuccinic acid (DMSA) in treatment of lead induced nephropathy in adult male albino ratsProtective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice.Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study
P2860
Q28079909-7AC5B853-A6ED-46B1-898E-5B5E8BC66120Q28468288-390AEE15-6BFA-402F-B4C7-F029DA7EC365Q33598219-84310813-6A5D-479E-993E-20C11C507A57Q36017190-4CB4E5F8-CD94-431F-A8A0-9AFD9CE87BE4Q37149008-A149F326-4C11-42EA-8A2E-009508030CD0Q37314378-DED60503-A761-4223-91B9-3FE3609781D5Q37646391-F5B8F4CB-1E80-48FD-BA75-249B156340E6Q38374851-13D3141B-F3B8-43E4-8EED-3768993E048BQ38604792-37CC55CF-58A5-4CFF-B4DB-6859EDBA4C44Q39413673-1467528C-2B24-41CC-96C7-F1358D494BEBQ41124277-2170B1E5-336B-46D4-A734-8AD534B727C3Q41680325-9A7A9467-A6E2-4914-9244-6AD53816855DQ42527938-4B65EC15-C7AC-4473-B3A0-9B05161F397DQ55360734-4CBCD3C7-131E-4A99-BF2F-8702F0E877C0Q58739819-0E70210D-9076-496E-AA19-13021ABA64FE
P2860
"Silymarin", a promising pharmacological agent for treatment of diseases
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
"Silymarin", a promising pharmacological agent for treatment of diseases
@ast
"Silymarin", a promising pharmacological agent for treatment of diseases
@en
"Silymarin", a promising pharmacological agent for treatment of diseases
@nl
type
label
"Silymarin", a promising pharmacological agent for treatment of diseases
@ast
"Silymarin", a promising pharmacological agent for treatment of diseases
@en
"Silymarin", a promising pharmacological agent for treatment of diseases
@nl
prefLabel
"Silymarin", a promising pharmacological agent for treatment of diseases
@ast
"Silymarin", a promising pharmacological agent for treatment of diseases
@en
"Silymarin", a promising pharmacological agent for treatment of diseases
@nl
P2093
P2860
P1476
"Silymarin", a promising pharmacological agent for treatment of diseases
@en
P2093
Gholamreza Karimi
Maryam Vahabzadeh
Marziyeh Rashedinia
Mohammad Moshiri
Parisa Lari
P2860
P304
P577
2011-07-01T00:00:00Z